Profilo
Jason Barker served as Managing Director at Bauer York LLC from 2011 to 2015.
Prior to that, he was the Chief Accounting Officer & Head-Finance at ARYx Therapeutics, Inc. from 2009 to 2011.
He also served as the Chief Financial Officer at Zosano Pharma Corp.
Additionally, he briefly served as the Chief Financial Officer at Astellas Gene Therapies, Inc. in 2015.
In 2019, he became the VP, Chief Financial & Accounting Officer at Arcus Biosciences, Inc. Barker received his undergraduate degree from The University of Texas at Austin.
Precedenti posizioni note di Jason Barker
| Società | Posizione | Fine |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Direttore Finanziario/CFO | 01/08/2020 |
| AUDENTES THERAPEUTICS, INC. | Direttore Finanziario/CFO | 29/09/2015 |
Bauer York LLC | Corporate Officer/Principal | 01/01/2015 |
| ARYX THERAPEUTICS, INC. | Direttore Finanziario/CFO | 09/07/2009 |
| ZOSANO PHARMA CORPORATION | Direttore Finanziario/CFO | - |
Formazione di Jason Barker
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zosano Pharma Corp.
Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that specializes in the systemic administration of therapeutics | Health Technology |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Bauer York LLC |
















